How to Avoid Denials for Inpatient Transcatheter Aortic Valve Replacement (TAVR) Services

Published 04/29/2021

This article applies to providers who bill inpatient claims for the performance of a Transcatheter Aortic Valve Replacement (TAVR). This procedure is used for the treatment of aortic stenosis when furnished according to the Food and Drug Administration (FDA)-approved indications. Documentation must support that certain conditions are met as outlined in the National Coverage Determination (NCD) for Transcatheter Aortic Valve Replacement (TAVR) (20.32).

The Comprehensive Error Rate Testing (CERT) contractor has issued errors resulting in a denial of inpatient claims due to missing documentation to support the need for the TAVR procedure. The submitted medical records were missing evidence that a cardiac surgeon and an interventional cardiologist experienced in the care and treatment of aortic stenosis have independently examined the patient face-to-face and evaluated the patient's suitability for open aortic valve replacement (AVR) surgery. Both the surgeon and interventional cardiologist must document the rationale for their clinical judgment and that the rationale was available to the heart team. In addition, the heart team's interventional cardiologist(s) and cardiac surgeon(s) must jointly participate in the intra-operative technical aspects of TAVR.

As a reminder, this documentation is just one of the requirements that must be met in order to determine medical necessity for this procedure. The NCD 20.32, Transcatheter Aortic Valve Replacement (TAVR), includes all the covered indications and limitations of coverage for this procedure. Providers should ensure that all documentation to support the medical necessity for this procedure is submitted when requested by CERT and other Medicare contractors.

References: National Coverage Determination (NCD) for Transcatheter Aortic Valve Replacement (TAVR) (20.32).

Was this article helpful?